Table 1 Clinical features of patients with abnormal (G1) and normal (G2) exercise echocardiography
From: Prognostic value of exercise echocardiography in diabetic patients
VARIABLES | G1 (n = 92) | G2 (n = 101) | P |
|---|---|---|---|
Males (%) | 44 (47.8%) | 53 (52.5%) | 0.52 |
Age (Years) | 60.4 ± 9.5 | 59.3 ± 9.1 | 0.42 |
Systemic Hypertension (%) | 81 (88%) | 90 (89.1%) | 0.82 |
Fasting Plasma Glucose | 143.0 ± 44.1 | 149.2 ± 42.6 | 0.83 |
Total Cholesterol | 187.0 ± 47.8 | 191.6 ± 45.5 | 0.95 |
HDL-Cholesterol | 50.7 ± 16.8 | 48.3 ± 13.0 | 0.55 |
LDL-Cholesterol | 109.5 ± 46.8 | 110.1 ± 40.3 | 0.7 |
Triglycerides | 163.2 ± 142.8 | 173.9 ± 83.2 | 0.43 |
Cigarette Smoking (%) | 22 (23.9%) | 19 (18.8%) | 0.39 |
Sedentary (%) | 45 (48.9%) | 45 (44.6%) | 0.54 |
BMI | 27.9 ± 4.2 | 28.9 ± 3.8 | 0.11 |
Family History of IHD (%) | 38 (41.3%) | 34 (33.7%) | 0.27 |
Alcoholism (%) | 40 (43.5%) | 45 (44.6%) | 0.88 |
Insulin Therapy (%) | 32 (34.8%) | 20 (19.8%) | 0.02 |
Oral Hypoglycemic Agents (%) | 68 (73.9%) | 83 (82.2%) | 0.16 |
Beta Blocker Therapy (%) | 43 (47.8%) | 29 (29.3%) | 0.009 |
Nitrates Therapy (%) | 33 (36.7%) | 6 (6.1%) | <0.001 |
Ca++Channel Blocker Therapy (%) | 33 (36.7%) | 30 (30.3%) | 0.35 |